✦ LIBER ✦

Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes

✍ Scribed by Bastiaan Nuijen; Marjan Bouma; Jan H.M. Schellens; Jos H. Beijnen

Book ID: 110294345
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 112 KB
Volume: 19
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1010682916808

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress in the development of alternati

Progress in the development of alternative approaches

✍ Silvia Casati; Costanza Rovida 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Development of spectrofluorimetric metho

Development of spectrofluorimetric methods for the determination of levosulpiride in pharmaceutical formulation

✍ Shaista Bano; Ayaz Mohd; Aftab Aslam Parwaz Khan; K. S. Siddiqi 📂 Article 📅 2011 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 274 KB

Concept and progress in the development

Concept and progress in the development of RGD-containmg peptide pharmaceuticals

✍ William S. Craig; Soan Cheng; Daniel G. Mullen; Jon Blevitt; Michael D. Pierschb 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 106 KB 👁 2 views

The cell adhesion domain, arginine-glycine-aspartic acid (RGD), has been incorporated into synthetic peptides to perform either of two modes of drug action, antagonist or agonist. Short, conformationally constrainedpeptides have been developed as antagonists for the platelet membrane glycoprotein co

Development of a Validated Stability-Ind

Development of a Validated Stability-Indicating LC Method for Nitazoxanide in Pharmaceutical Formulations

✍ Marcelo Donadel Malesuik; Simone Gonçalves Cardoso; Martin Steppe 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 261 KB

Contribution of cyclodextrins in the dev

Contribution of cyclodextrins in the development of different pharmaceutical formulations of a new matrix metalloproteinase inhibitor

✍ B. Evrard; P. Bertholet; M. Gueders; M. Piette; G. Piel; D. Cataldo; L. Delattre 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 187 KB

Progress in preclinical and clinical stu

Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes

✍ N. Saijo; Kazuto Nishio; S. Ohta; Hitoshi Arioka; Yasunori Funayama; Kazuya Fuku 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 108 KB